[Potential for the clinical use of intranasal rifathyroin for diagnosis and treatment].
Starkova Nt, Butrova Sa, Surkov Si, Kotova Ga, Nazarov An, Bobrovskaia Ta
Abstract
Starkova Nt, Butrova Sa, Surkov Si, Kotova Ga, Nazarov An, Bobrovskaia Ta
Abstract
It has been shown that stimulated TSH and prolactin levels in intranasal administration of rifathyroin are comparable with the results of i.v. administration of the drug. Intranasal administration can be used for both therapeutic and diagnostic purposes.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
It has been shown that stimulated TSH and prolactin levels in intranasal administration of rifathyroin are comparable with the results of i.v. administration of the drug. Intranasal administration can be used for both therapeutic and diagnostic purposes.
Key concepts: Nasal administration, Administration (probate law), Medicine, Drug administration, Food and drug administration, Prolactin, Drug, Pharmacology